Mutations in glycyl-tRNA-synthetase impair mitochondrial metabolism in neurons

Abstract

The nuclear-encoded glycyl-tRNA synthetase gene (GARS) is essential for protein translation in both cytoplasm and mito-chondria. In contrast, different genes encode the mitochondrial and cytosolic forms of most other tRNA synthetases.Dominant GARS mutations were described in inherited neuropathies, while recessive mutations cause severe childhood-onset disorders affecting skeletal muscle and heart. The downstream events explaining tissue-specific phenotype–genotyperelations remained unclear. We investigated the mitochondrial function ofGARSin human cell lines and in the Gars C210R mouse model. Human-induced neuronal progenitor cells (iNPCs) carrying dominant and recessive GARS mutations showedalterations of mitochondrial proteins, which were more prominent in iNPCs with dominant, neuropathy-causing mutations. Although comparative proteomic analysis of iNPCs showed significant changes in mitochondrial respiratory chain complex subunits, assembly genes, Krebs cycle enzymes and transport proteins in both recessive and dominant mutations, proteins involved in fatty acid oxidation were only altered by recessive mutations causing mitochondrial cardiomyopathy. In contrast,significant alterations of the vesicle-associated membrane protein-associated protein B (VAPB) and its downstream pathways such as mitochondrial calcium uptake and autophagy were detected in dominant GARS mutations. The role of VAPB has beensupported by similar results in the GarsC210Rmice. Our data suggest that altered mitochondria-associated endoplasmic reticu-lum (ER) membranes (MAM) may be important disease mechanisms leading to neuropathy in this condition